Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.6T | 10.8T | 10.9T | 10.3T |
| Cost of revenue | 4.1T | 3.6T | 3.8T | 3.6T |
| Gross profit | 7.5T | 7.2T | 7.1T | 6.7T |
| Operating expense | ||||
| Research & development | 887.8B | 876.2B | 904.7B | 877.4B |
| Selling general and admin | 3.5T | 3.5T | 3.6T | 3.4T |
| Other operating expenses | 19.5B | -6.5B | -44.1B | 1.3B |
| Operating income | 2.3T | 2.2T | 2.1T | 1.8T |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 225.9B | 232.3B | 271.3B | 216.8B |
| Other income expense | -468.6B | 9.1B | 185.6B | 37.6B |
| Pretax income | 1.6T | 2.0T | 2.0T | 1.6T |
| Tax provision | 258.3B | 307.6B | 364.7B | 285.6B |
| Net income | 1.4T | 1.7T | 1.7T | 1.4T |
| Basic EPS | — | 2.0 | 2.0 | 1.6 |
| Diluted EPS | — | 2.0 | 2.0 | 1.6 |
| Basic average shares | — | 832.3B | 832.3B | 839.4B |
| Diluted average shares | — | 834.7B | 835.2B | 841.4B |
| EBITDA | 3.4T | 3.2T | 3.2T | 2.9T |
| Net income from continuing op. | 1.4T | 1.7T | 1.7T | 1.4T |
| Minority interests | -6.5B | -11.7B | -11.7B | -7.8B |
| Preferred stock dividends | — | — | — | — |